Tuberculosis

Introducing fast and accurate tests where patients seek care

Malaria & Acute febrile syndrome (AFS)

Assuring quality of existing rapid tests and developing new tools

Neglected tropical diseases (NTDs)

Contributing to elimination through new and improved tests

Ebola

Partnering to deliver the right tools to the right places

Access

Projects reach important milestones

  • 1
  • 2
  • 3
  • 4
  • 5

Latest News

Update on Diagnostics for Ebola Control

26 January 2015

On 12 December 2014, FIND and the WHO hosted a joint meeting on Diagnostics and Ebola Control with representatives from Médecins Sans Frontières, policy makers, partner organizations, regulators from Ebola-affected countries, and implementing agencies. Both the full Summary Report of the meeting and Executive Summary are now available.

FIND appoints Director of Swiss TPH to its Board of Directors

23 January 2015

FIND announced today the appointment of Dr Marcel Tanner, Director of the Swiss Tropical and Public Health Institute (Swiss TPH) to its Board of Directors. Dr Tanner has chaired FIND’s Scientific Advisory Committee since 2013. He joins a Board of eight global health and diagnostics industry specialists chaired by Mark Kessel.

Request for Proposals

14 January 2015

FIND is issuing a request for proposals inviting applications from institutions or organizations to prepare an updated market assessment for HIV incidence assays. A reliable measure of HIV incidence is essential for tracking population-based changes in the HIV/AIDS epidemic, and for understanding the impact of intervention and prevention programmes in LMICs.

Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load

29 December 2014

SUNNYVALE, Calif. and GENEVA, Dec. 29, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) and FIND today announced that Xpert® HIV-1 Viral Load, a quantitative test for measurement of the HIV-1 viral load in plasma, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on the Cepheid GeneXpert® System, the world's leading molecular diagnostic platform with over 7,500 systems deployed globally in both developed and emerging market countries.

right column